Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer.

Autor:	Rocha-Filho DR; Hospital Universitário Walter Cantídio, 60430-372 Fortaleza, Brazil.; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Peixoto RD; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Weschenfelder RF; Hospital Moinhos de Vento, 90035-000 Porto Alegre, Brazil., Rego JFM; Hospital Universitário Onofre Lopes, 59012-300 Natal, Brazil., Riechelmann R; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Coutinho AK; Clínica AMO, 41.950-640 Salvador, Brazil., Fernandes GS; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Jacome AA; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Andrade AC; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Murad AM; Laboratório Personal, 30130-090 Fortaleza, Brazil., Mello CAL; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Miguel DSCG; Clínica AMO, 41.950-640 Salvador, Brazil., Gomes DBD; Hospital Israelita Albert Einstein, 05652-900, São Paulo, Brazil., Racy DJ; Hospital Beneficência Portuguesa de São Paulo, 01323-001 São Paulo, Brazil., Moraes ED; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Akaishi EH; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Carvalho ES; Hospital São Rafael, 41253-190 Salvador, Brazil., Mello ES; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Filho FM; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Coimbra FJF; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Capareli FC; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Arruda FF; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Vieira FMAC; Américas Oncologia, 22775-001 Rio de Janeiro, Brazil., Takeda FR; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Cotti GCC; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Pereira GLS; Centro de Oncologia do Paraná, 81200-100 Curitiba, Brazil., Paulo GA; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Ribeiro HSC; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Lourenco LG; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Crosara M; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Toneto MG; Hospital São Lucas da PUCRS, 90610-000 Porto Alegre, Brazil., Oliveira MB; Faculdade de Ciências Médicas da Santa Casa de São Paulo, 01238-010 São Paulo, Brazil., de Lourdes Oliveira M; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Begnami MD; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Forones NM; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Yagi O; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Ashton-Prolla P; Hospital de Clínicas de Porto Alegre, 90035-903 Porto Alegre, Brazil., Aguillar PB; Hospital Alemão Oswaldo Cruz, 01323-020 São Paulo, Brazil., Amaral PCG; Clínica AMO, 41.950-640 Salvador, Brazil., Hoff PM; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Araujo RLC; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Di Paula Filho RP; Hospital Alemão Oswaldo Cruz, 01323-020 São Paulo, Brazil., Gansl RC; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Gil RA; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Pfiffer TEF; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Souza T; Hospital Aliança de Salvador, 41920-900 Salvador, Brazil., Ribeiro U Jr; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Jesus VHF; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Costa WL Jr; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Prolla G; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Jazyk:	angličtina
Zdroj:	Ecancermedicalscience [Ecancermedicalscience] 2021 Mar 02; Vol. 15, pp. 1195. Date of Electronic Publication: 2021 Mar 02 (Print Publication: 2021).
DOI:	10.3332/ecancer.2021.1195
Abstrakt:	Oesophageal cancer is among the ten most common types of cancer worldwide. More than 80% of the cases and deaths related to the disease occur in developing countries. Local socio-economic, epidemiologic and healthcare particularities led us to create a Brazilian guideline for the management of oesophageal and oesophagogastric junction (OGJ) carcinomas. The Brazilian Group of Gastrointestinal Tumours invited 50 physicians with different backgrounds, including radiology, pathology, endoscopy, nuclear medicine, genetics, oncological surgery, radiotherapy and clinical oncology, to collaborate. This document was prepared based on an extensive review of topics related to heredity, diagnosis, staging, pathology, endoscopy, surgery, radiation, systemic therapy (including checkpoint inhibitors) and follow-up, which was followed by presentation, discussion and voting by the panel members. It provides updated evidence-based recommendations to guide clinical management of oesophageal and OGJ carcinomas in several scenarios and clinical settings. Competing Interests: Duilio R Rocha-Filho: personal fees from Bayer, Merck Serono and Servier. Renata D’Alpino Peixoto: personal fees from Lilly and MSD. Anelisa K Coutinho: personal fees from Amgen, Bayer, Roche, MSD, Merck Serono, Sanofi, Servier, Ipsen, Novartis and United Medical. Juliana F M Rego: personal fees from Novartis, Bayer, Amgen and Ipsen. Rachel Riechelmann: research grants from Libbs (gastric consensus only). Rui F Weschenfelder: personal fees from Lilly, MSD and Roche. Alexandre A Jacome: personal fees from Roche, Novartis, Zodiac and Pfizer. Research grants from Bayer. Celso A L Mello: personal fees from Lilly, Merck Serono, MSD and Roche. Gustavo S Fernandes: personal fees from BMS, Bayer and Roche. Roberto A Gil: personal fees from Amgen, Bayer, Lilly, Merck Serono, Roche, Sanofi and United Medical. Research grant from Amgen, Bayer, Merck and Roche. Victor Hugo F Jesus: personal fees from United Medical. (© the authors; licensee ecancermedicalscience.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF